Celcuity Announced Overall Survival Data From Two Patient Cohorts Evaluated In A Phase 1B Trial With Gedatolisib, A PI3K/mTORC1/2 Inhibitor, In Combination With Palbociclib And Either Letrozole Or Fulvestrant, In Patients With HR+, HER2-advanced Or...

Benzinga13minutes ago

BofA Securities Maintains Celsius Holdings(CELH.US) With Sell Rating, Maintains Target Price $26

Futu News18:33 · Ratings

Analysts Offer Insights on Consumer Goods Companies: Constellation Brands (STZ) and Celsius Holdings (CELH)

TipRanks18:10 · Ratings

Celsius Holdings Options Spot-On: On December 10th, 165.83K Contracts Were Traded, With 608.83K Open Interest

On December 10th ET, $Celsius Holdings(CELH.US)$ had active options trading, with a total trading volume of 165.83K options for the day, of which put options accounted for 13.29% of the total

Futu News05:30

(CELH) - Analyzing Celsius Holdings's Short Interest

Benzinga00:45

Celsius Holdings Options Spot-On: On December 9th, 102.4K Contracts Were Traded, With 612.83K Open Interest

On December 9th ET, $Celsius Holdings(CELH.US)$ had active options trading, with a total trading volume of 102.4K options for the day, of which put options accounted for 32.66% of the total

Futu NewsDec 10 05:30